Primary immunodeficiency diseases (PIDD) and secondary immunodeficiencies create a category of patients who require lifelong, highly structured medical support. For patients with common variable immunodeficiency (CVID), X-linked agammaglobulinemia, and other antibody deficiencies, immunoglobulin replacement therapy—administered either intravenously (IVIG) or subcutaneously (SCIG)—is not a temporary treatment but a permanent dependency. These patients require infusions every three to four weeks for IVIG, or weekly for SCIG, generating one of the most consistent and intensive administrative workloads in outpatient specialty medicine.
Immunodeficiency specialty clinics that fail to build robust administrative systems around this patient population face chronic prior authorization delays, infusion interruptions, and billing errors that affect both patient safety and practice revenue. In 2026, leading immunodeficiency clinics are leveraging virtual assistants to stabilize and scale these operations.
Prior Authorization for Immunoglobulin Therapy
Immunoglobulin products—including Gammagard, Privigen, Hizentra, and Cuvitru—are among the highest-cost infused drugs in outpatient medicine. Commercial insurers and Medicare require prior authorization for each product, with annual or semi-annual re-authorization requirements. Payers often require documentation of IgG trough levels, infection history, and failure of alternative treatments.
A virtual assistant manages the full PA lifecycle: tracking authorization expiration dates for every patient in the panel, preparing re-authorization packages with current lab values and clinical documentation, and submitting to payer portals before expiration windows close. When denials occur, the VA prepares appeal documentation and initiates the peer-to-peer review process, ensuring that patients do not experience treatment gaps while administrative reviews proceed.
IVIG Infusion Suite Scheduling
In-office IVIG infusions require scheduling precision. Infusion durations range from two to eight hours depending on the product, dose, and patient tolerance. Nursing ratios, chair availability, and pre-medication protocols must all be coordinated. When authorization status changes—a frequent occurrence—the scheduling calendar must be updated immediately to avoid chair cancellations.
A VA maintains the infusion scheduling calendar in real time, confirming authorization status before each appointment is finalized, sending pre-infusion preparation instructions, and coordinating with specialty pharmacies or hospital pharmacy partners on drug delivery. For patients on SCIG who self-administer at home, the VA manages prescription refill coordination, supply delivery tracking, and nursing training appointment scheduling.
Home Infusion and SCIG Program Support
Subcutaneous immunoglobulin is increasingly preferred by both patients and payers for stable patients. Transitioning a patient from IVIG to SCIG involves a training program, supply enrollment with a home infusion company, and prior authorization for the new product and route. A VA coordinates the full transition: completing payer prior authorization for the SCIG product, enrolling patients with the home infusion vendor, scheduling training sessions, and following up after the first home infusion to confirm the patient is managing the process correctly.
IgG Trough Level Monitoring
Maintaining therapeutic IgG trough levels is the primary clinical goal of immunoglobulin replacement. This requires periodic pre-infusion IgG level monitoring and dose adjustments. A VA manages the lab order reminder calendar, ensures that trough levels are drawn at the appropriate pre-infusion interval, and routes results to the treating physician for dose review before the next infusion appointment.
Billing for IVIG and SCIG Services
Immunoglobulin infusion billing is technically demanding. IVIG billing involves drug administration codes (96365-96368), drug product codes (J-codes for specific products and doses), and physician oversight codes. Errors in drug unit counting, J-code selection, or administration code sequencing create significant revenue losses and audit risk.
A VA with immunology infusion billing training prepares claims with correct J-codes and administration units, reviews remittance for drug payment shortfalls, and manages the appeals process for payers that apply average sales price policies that differ from the practice's acquisition cost.
Patient Support and Advocacy
Immunodeficiency patients often face a long diagnostic journey before receiving appropriate treatment. Once diagnosed, they benefit from active patient support—education about their condition, connection to the Immune Deficiency Foundation patient registry, and guidance on navigating insurance coverage. A VA supports this function by distributing educational resources at diagnosis, coordinating patient assistance program applications for patients with coverage gaps, and maintaining ongoing communication throughout the treatment relationship.
Immunodeficiency clinics ready to build a scalable administrative infrastructure can explore dedicated support at Stealth Agents.
Sources
- Immune Deficiency Foundation, "Primary Immunodeficiency Disease Statistics 2025," primaryimmune.org
- American Academy of Allergy, Asthma & Immunology, "Immunoglobulin Therapy Practice Guidelines 2024," aaaai.org
- Medical Group Management Association, "Infusion Therapy Practice Operations 2025," mgma.com